Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 2/20 | 0.37 |
| ▸ | FPR2 | P25090 | 3/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 7/20 | 0.35 |
| ▸ | ESR1 | P03372 | 6/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.35 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.35 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.34 |
| ▸ | FGFR2 | P21802 | 1/20 | 0.34 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.33 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.32 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.32 |
| ▸ | PTPRC | P08575 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26209578 | 1.00 | KDM1A (0.37) | KDM1AFPR2ESR2ESR1CYP2C9 | |
| SCHEMBL26455653 | 0.92 | ESR2 (0.39) | KDM1AFPR2ESR2ESR1CYP2C9 | |
| SCHEMBL4402648 | 0.92 | KDM1A (0.37) | KDM1AFPR2ESR2ESR1CYP2C9 | |
| SCHEMBL17715213 | 0.92 | KDM1A (0.37) | KDM1AFPR2ESR2ESR1CYP2C9 | |
| SCHEMBL29432462 | 0.90 | CYP2C9 (0.44) | KDM1AFPR2ESR2ESR1CYP2C9 | |
| SCHEMBL2604710 | 0.90 | CYP2C9 (0.44) | KDM1AFPR2ESR2ESR1CYP2C9 | |
| SCHEMBL26209573 | 0.90 | CYP2C9 (0.44) | KDM1AFPR2ESR2ESR1CYP2C9 | |
| SCHEMBL4402617 | 0.90 | CYP2C9 (0.44) | KDM1AFPR2ESR2ESR1CYP2C9 | |
| SCHEMBL17827784 | 0.89 | KDM1A (0.39) | KDM1AFPR2CYP2C9CYP3A4GRIN1 | |
| SCHEMBL26209577 | 0.89 | KDM1A (0.39) | KDM1AFPR2CYP2C9CYP3A4GRIN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4400561-A1 | LIQUID-CRYSTAL MEDIUM | Merck Patent GmbH (DE) | 2024-07-17 | — | — | EP | disclosed |
| US-20240067879-A1 | Liquid-crystal medium | MERCK PATENT GMBH (DE) | 2024-02-29 | — | — | US | disclosed |
| US-20240067879-A1 | Liquid-crystal medium | MERCK PATENT GMBH (DE) | 2024-02-29 | — | — | US | disclosed |
| EP-4306615-A1 | LIQUID-CRYSTAL MEDIUM | Merck Patent GmbH (DE) | 2024-01-17 | — | — | EP | disclosed |
| US-20230383186-A1 | LIQUID-CRYSTAL MEDIUM | MERCK PATENT GMBH (DE) | 2023-11-30 | — | — | US | disclosed |
| US-20230383186-A1 | LIQUID-CRYSTAL MEDIUM | MERCK PATENT GMBH (DE) | 2023-11-30 | — | — | US | disclosed |
| US-20230357637-A1 | LIQUID-CRYSTAL MEDIUM | MERCK PATENT GMBH (DE) | 2023-11-09 | — | — | US | disclosed |
| US-20230357637-A1 | LIQUID-CRYSTAL MEDIUM | MERCK PATENT GMBH (DE) | 2023-11-09 | — | — | US | disclosed |
| EP-4273207-A1 | LIQUID-CRYSTAL MEDIUM | Merck Patent GmbH (DE) | 2023-11-08 | — | — | EP | disclosed |
| EP-4261267-A1 | LIQUID-CRYSTAL MEDIUM | Merck Patent GmbH (DE) | 2023-10-18 | — | — | EP | disclosed |
| EP-4261268-A1 | LIQUID CRYSTAL MEDIUM | Merck Patent GmbH (DE) | 2023-10-18 | — | — | EP | disclosed |
| US-20230323209-A1 | LIQUID-CRYSTAL MEDIUM | MERCK PATENT GMBH (DE) | 2023-10-12 | — | — | US | disclosed |
| US-20230323209-A1 | LIQUID-CRYSTAL MEDIUM | MERCK PATENT GMBH (DE) | 2023-10-12 | — | — | US | disclosed |
| US-20230272282-A1 | LC MIXTURES WITH NEGATIVE DELTA EPSILONCONTAINING CC-4-V1 AND COB(S)-N-OM | MERCK PATENT GMBH (DE) | 2023-08-31 | — | — | US | disclosed |
| US-11046888-B2 | Difluoromethoxy-bridge liquid crystal compound containing methyl-substituted 2,3-difluorophenyl and crystal composition | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIAL CO., LTD. (CN) | 2021-06-29 | — | — | US | disclosed |
| US-10519377-B1 | Liquid crystal composition of negative monomer containing cyclopentyl cyclohexenyl and liquid crystal display element or liquid crystal display thereof | Shijiazhuang Chengzhi Yonghua Display Material Co., Ltd (CN) | 2019-12-31 | — | — | US | disclosed |
| US-20190345388-A1 | DIFLUOROMETHOXY-BRIDGE LIQUID CRYSTAL COMPOUND CONTAINING METHYL-SUBSTITUTED 2,3-DIFLUOROPHENYL AND CRYSTAL COMPOSITION | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIAL CO., LTD. (CN) | 2019-11-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190345388-A1 | DIFLUOROMETHOXY-BRIDGE LIQUID CRYSTAL COMPOUND CONTAINING METHYL-SUBSTITUTED 2,3-DIFLUOROPHENYL AND CRYSTAL COMPOSITION | CCDC22, YTHDC1, DLK1 | KDM1A 438/4885FPR2 1367/4885ESR2 2725/4885 |
| US-11046888-B2 | Difluoromethoxy-bridge liquid crystal compound containing methyl-substituted 2,3-difluorophenyl and crystal composition | CCDC22, YTHDC1, DLK1 | KDM1A 438/4885FPR2 1367/4885ESR2 2725/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.